What is the price target for Prometheus Biosciences stock?
View Prometheus Biosciences' earnings history. What price target have analysts set for RXDX? 7 Wall Street analysts have issued 1 year price targets for Prometheus Biosciences' stock. Their forecasts range from $30.00 to $50.00.
Where to buy Prometheus Biosciences'RXDX?
Shares of RXDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Prometheus Biosciences' stock price today?
Why Prometheus Laboratories?
At Prometheus Laboratories, we have an unwavering commitment to optimizing patient care and treatment outcomes. We understand that each person’s health journey is unique and we help clinicians and patients make critical treatment decisions with novel testing services.
Is Prometheus Biosciences a good stock to buy?
Prometheus Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.
Is Prometheus publicly traded?
Prometheus' common stock is listed on the Nasdaq Global Select Market under the ticker symbol "RXDX".
When did Prometheus Biosciences go public?
March 12, 2021The shares are expected to begin trading on the Nasdaq Global Select Market on March 12, 2021 under the ticker symbol "RXDX". The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Prometheus, are expected to be $190 million.
How do I invest in Prometheus?
How to buy shares in Prometheus BiosciencesCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Is RXDX stock a buy right now?
7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Prometheus Biosciences in the last twelve months. There are curre...
Will Prometheus Biosciences' stock price go up in 2022?
7 Wall Street research analysts have issued 12-month price objectives for Prometheus Biosciences' stock. Their forecasts range from $45.00 to $62.0...
How has Prometheus Biosciences' stock price performed in 2022?
Prometheus Biosciences' stock was trading at $39.54 on January 1st, 2022. Since then, RXDX shares have decreased by 26.7% and is now trading at $29...
When is Prometheus Biosciences' next earnings date?
Prometheus Biosciences is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast...
How were Prometheus Biosciences' earnings last quarter?
Prometheus Biosciences, Inc. (NASDAQ:RXDX) issued its quarterly earnings results on Thursday, May, 12th. The biopharmaceutical company reported ($0...
Who are Prometheus Biosciences' key executives?
Prometheus Biosciences' management team includes the following people: Mr. Mark C. McKenna , Pres, CEO & Chairman (Age 42, Pay $2.22M) Dr. Keith...
Who are some of Prometheus Biosciences' key competitors?
Some companies that are related to Prometheus Biosciences include Cerevel Therapeutics (CERE) , Blueprint Medicines (BPMC) , Ultragenyx Pharmace...
What other stocks do shareholders of Prometheus Biosciences own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Prometheus Biosciences investors own include Cronos Group...
When did Prometheus Biosciences IPO?
(RXDX) raised $126 million in an initial public offering on Friday, March 12th 2021. The company issued 7,400,000 shares at $16.00-$18.00 per share...
When will Prometheus Biosciences release its earnings?
When does Prometheus Biosciences' lock up period expire?
Prometheus Biosciences is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021. View our earnings forecast for Prometheus Biosciences.
News & Analysis: Prometheus Biosciences, Inc
When does the company's lock-up period expire? Prometheus Biosciences' lock-up period expires on Wednesday, September 8th. Prometheus Biosciences had issued 10,000,000 shares in its public offering on March 12th. The total size of the offering was $190,000,000 based on an initial share price of $19.00.
Environmental, Social, and Governance Rating
There is no available coverage of Prometheus Biosciences, Inc. at this time.
Prometheus Fuels Comparisons
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
Prometheus Fuels Signals
Manufacturer of carbon-neutral fuels intended to remove CO2 from the air and turn it into gasoline and jet fuel. The com
